Endo International plc financial data

Industry
Pharmaceutical Preparations
Location
Minerva House, Simmonscourt Road, Ballsbridge, Dublin 4, Ireland
Fiscal year end
December 31
Former names
Endo International Ltd (to 1/27/2014)
Latest financial report
10-K - Q4 2023 - Mar 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 317 % +36.3%
Quick Ratio 47.5 % +58.5%
Return On Assets -45.8 % -4.18%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 235M shares 0%
Common Stock, Shares, Outstanding 235M shares +0.01%
Entity Public Float 4.08M USD -96.3%
Common Stock, Value, Issued 24K USD 0%
Weighted Average Number of Shares Outstanding, Basic 235M shares +0.16%
Weighted Average Number of Shares Outstanding, Diluted 235M shares +0.16%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.01B USD -13.3%
Cost of Revenue 946M USD -13.4%
Nonoperating Income (Expense) 9.69M USD -71.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.39B USD +17.2%
Income Tax Expense (Benefit) 55.9M USD +160%
Net Income (Loss) Attributable to Parent -2.45B USD +16.2%
Earnings Per Share, Basic -10.4 USD/shares +16.3%
Earnings Per Share, Diluted -10.4 USD/shares +16.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 778M USD -23.7%
Accounts Receivable, after Allowance for Credit Loss, Current 387M USD -21.7%
Inventory, Net 246M USD -10.4%
Assets, Current 1.67B USD -19.7%
Deferred Income Tax Assets, Net 8K USD -99.3%
Operating Lease, Right-of-Use Asset 23M USD -17.9%
Intangible Assets, Net (Excluding Goodwill) 1.48B USD -14.7%
Goodwill 1.35B USD 0%
Other Assets, Noncurrent 140M USD +7.54%
Assets 5.14B USD -10.8%
Contract with Customer, Liability, Current 600K USD 0%
Liabilities, Current 539M USD -21.9%
Deferred Income Tax Liabilities, Net 16.2M USD +17.5%
Operating Lease, Liability, Noncurrent 4.13M USD -19.4%
Other Liabilities, Noncurrent 79.8M USD +86.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -224M USD +1.4%
Retained Earnings (Accumulated Deficit) -15.4B USD -19%
Stockholders' Equity Attributable to Parent -6.6B USD -58.5%
Liabilities and Equity 5.14B USD -10.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 62.1M USD -69.2%
Net Cash Provided by (Used in) Financing Activities -145M USD +23.5%
Net Cash Provided by (Used in) Investing Activities -21.4M USD +56.3%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 235M shares +0.01%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -104M USD -185%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.03B USD -17.5%
Deferred Tax Assets, Valuation Allowance 16.9B USD +61.7%
Deferred Tax Assets, Gross 16.9B USD +60.7%
Operating Lease, Liability 5.09M USD -15.7%
Payments to Acquire Property, Plant, and Equipment 31.3M USD +35.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.45B USD +16.6%
Lessee, Operating Lease, Liability, to be Paid 28.4M USD -26.9%
Operating Lease, Liability, Current 956K USD +5.87%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.75M USD +2.24%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.14M USD -46.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.66M USD -39.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.5M USD +2.14%
Deferred Tax Assets, Operating Loss Carryforwards 15.5B USD +68%
Unrecognized Tax Benefits 592M USD +2.08%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.38M USD +0.81%
Operating Lease, Payments 2.74M USD -7.07%
Additional Paid in Capital 8.98B USD +0.13%
Amortization of Intangible Assets 65.3M USD -27.7%
Interest Expense 0 USD -100%